- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Working on Monkeypox vaccine: Serum Institute CEO
![Working on Monkeypox vaccine: Serum Institute CEO Working on Monkeypox vaccine: Serum Institute CEO](https://medicaldialogues.in/h-upload/2022/10/21/750x450_188683-adar-poonawalla-new.webp)
New Delhi: The Serum Institute of India has said that the Company is currently working on developing a Monkeypox vaccine to address the growing threat posed by the disease.
Mpox outbreak was declared a public health emergency of international concern by the World Health Organisation on August 14. The move came after a sudden increase in cases was recorded in parts of Africa.
In July 2022, the multi-country outbreak of mpox was declared a public health emergency of international concern as it spread rapidly via sexual contact across a range of countries where the virus had not been seen before. That public health emergency of international concern was declared over in May 2023 after there had been a sustained decline in global cases.
Mpox has been reported in the Democratic Republic of the Congo for more than a decade, and the number of cases reported each year has increased steadily over that period. Last year, reported cases increased significantly, and already the number of cases reported so far this year has exceeded last year’s total, with more than 15 600 cases and 537 deaths.
The emergence last year and rapid spread of a new virus strain in Democratic Republic of the Congo , clade 1b, which appears to be spreading mainly through sexual networks, and its detection in countries neighbouring the Democratic Republic of the Congo is especially concerning, and one of the main reasons for the declaration of the public health emergency of international concern.
In the past month, over 100 laboratory-confirmed cases of clade 1b have been reported in four countries neighbouring the Democratic Republic of the Congo that have not reported mpox before: Burundi, Kenya, Rwanda and Uganda.
Several outbreaks of different clades of mpox have occurred in different countries, with different modes of transmission and different levels of risk.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751